Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice

Clinical and Experimental Rheumatology

Volumn 30, Issue 2, 2012, Pages 164-170

  Snijders, Gijs F ^a   van den Ende, Cornelia H M ^a   van den Bemt, Bart J F ^a   van Riel, Piet L C M ^b   van den Hoogen, Frank H J ^a   den Broeder, Alfons A ^a  

^a SINT MAARTENSKLINIEK   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Analgesia; Hip osteoarthritis; Knee osteoarthritis; Non steroidal anti inflammatory drugs; Paracetamol

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ACCURACY; ADD ON THERAPY; ADULT; AGE; ANALGESIA; ARTICLE; ATTITUDE TO CHANGE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HIP OSTEOARTHRITIS; HIP PAIN; HUMAN; INTERNAL VALIDITY; JOINT RADIOGRAPHY; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUMERIC RATING SCALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT GLOBAL ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME; WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX PAIN SUBSCALE; WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX PHYSICAL FUNCTION SUBSCALE; WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX STIFFNESS SUBSCALE;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; COHORT STUDIES; DISABILITY EVALUATION; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN MANAGEMENT; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863743409     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. JORDAN KM, ARDEN NK, DOHERTY M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-55.
2. ZHANG W, DOHERTY M, ARDEN N et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669-81.
3. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000; 43: 1905-15.
4. ZHANG W, MOSKOWITZ RW, NUKI G et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137-62.
5. HERNANDEZ-DIAZ S, RODRIGUEZ LA Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-9.
6. MCGETTIGAN P, HENRY D Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006; 296: 1633-44.
7. BJORDAL JM, LJUNGGREN AE, KLOVNING A, SLORDAL L Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: metaanalysis of randomised placebo controlled trials. BMJ 2004; 329: 1317.
8. TOWHEED TE, MAXWELL L, JUDD MG, CATTON M, HOCHBERG MC, WELLS G Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006; (1): CD004257.
9. VAN DEN ENDE CM, BIERMA-ZEINSTRA SM, VLIET VLIELAND TP, SWIERSTRA BA, VOORN TB, DEKKER J [Conservative treatment of hip and knee osteoarthritis:a systematic, step-by-step treatment strategy]. Ned Tijdschr Geneeskd 2010; 154: A1574.
10. SNIJDERS GF, DEN BROEDER AA, VAN RIEL PL et al. Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing. Scand J Rheumatol 2011; 40: 225-31.
11. ALTMAN R, ALARCON G, APPELROUTH D et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
12. ALTMAN R, ASCH E, BLOCH D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49.
13. KELLGREN JH, LAWRENCE JS Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
14. DE GROOT, I, FAVEJEE MM, REIJMAN M, VERHAAR JA, TERWEE CB The Dutch version of the Knee Injury and Osteoarthritis Outcome Score: a validation study. Health Qual Life Outcomes 2008; 6: 16.
15. DE GROOT, I, REIJMAN M, TERWEE CB et al. Validation of the Dutch version of the Hip disability and Osteoarthritis Outcome Score. Osteoarthritis Cartilage 2007; 15: 104-9.
16. BELLAMY N, BUCHANAN WW, GOLDSMITH CH, CAMPBELL J, STITT LW Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
17. WARE JE, JR., SHERBOURNE CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
18. FRANSEN J, LAAN RF, VAN DER LAAR MA, HUIZINGA TW, VAN RIEL PL Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1222-6.
19. TUBACH F, RAVAUD P, BARON G et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005; 64: 34-7.
20. CLEGG DO, REDA DJ, HARRIS CL et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354: 795-808.
21. WESSELING J, DEKKER J, VAN DEN BERG WB et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann Rheum Dis 2009; 68: 1413-9.
22. VAN DIJK GM, VEENHOF C, SPREEUWENBERG P et al. Prognosis of limitations in activities in osteoarthritis of the hip or knee: a 3-year cohort study. Arch Phys Med Rehabil 2010; 91: 58-66.
23. BINGHAM CO 3RD, SMUGAR SS, WANG H, PELOSO PM, GAMMAITONI A Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. Pain Med 2011; 12: 352-61.
24. DETORA LM, KRUPA D, BOLOGNESE J, SPERLING RS, EHRICH EW Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors. J Rheumatol 2001; 28: 2494-503.
25. WALKER JS, SHEATHER-REID RB, CARMODY JJ, VIAL JH, DAY RO Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". Arthritis Rheum 1997; 40: 1944-54.
26. BINGHAM III CO SMUGAR SS, WANG H, TERSHAKOVEC AM Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo. Rheumatology (Oxford) 2009; 48: 1122-7.
27. BATTISTI WP, KATZ NP, WEAVER AL et al. Pain management in osteoarthritis: a focus on onset of efficacy - a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials. J Pain 2004; 5: 511-20.
28. WEGMAN AC, VAN DER WINDT DA, DE HAAN M, DEVILLE WL, FO CT, DE VRIES TP Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Ann Rheum Dis 2003; 62: 1156-61.
29. LANE NE, SCHNITZER TJ, BIRBARA CA et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010; 363: 1521-31.